Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

TERG hosts seminar by Prof. Katja Schenke-Layland

20 October 2016

The TERG hosted a guest seminar by Prof. Katja Schenke-Layland on Wednesday, 12 October.

The Schenke-Layland Lab focuses on the translation of human development into clinically relevant biomaterials and regenerative therapies and the development of diagnostic tools to discover and validate therapeutic candidates and diagnose disease.

A focus of Katja’s current work has been the production of synthetic, biocompatible carrier material to mimic the biological structure of the developing human heart. The scaffolds are designed to attract endothelial progenitor cells circulating in the blood that can repopulate the valve. These cells will begin to modify and rebuild the synthetic scaffolds while in the body, allowing for the potential growth of the scaffolds with the ultimate goal of further developing this support material to a cell-free off-the-shelf heart valve.

Prof Katja Schenke-LaylandPr'Extracellular matrix and its role in biomedical research'
Prof. Katja Schenke-Layland, Professor of Biomaterials in Cardiovascular Regenerative Medicine

Prof. Katja Schenke-Layland completed her MSc in biology, psychology and sociology in 2001 before receiving her doctorate degree in biology in 2004 from the Friedrich Schiller University (FSU), Jena, Germany, where she worked as a researcher in the Departments of Anatomy (2000-2001) and Cardiothoracic Surgery (2001-2004).

She was a postdoctoral research fellow at the Saban Research Institute at the University of Southern California’s Children’s Hospital Los Angeles (2004-2005) and then at the David Geffen School of Medicine at the University of California Los Angeles (UCLA) between 2005 and 2008. In 2008, Katja was appointed as Research Professor in the Department of Medicine/Cardiology at UCLA (-2009) and is currently an Adjunct Associate Professor. In January 2010, she became the leader of the Fraunhofer-Attract Group at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Department of Cell and Tissue Engineering in Stuttgart, Germany where she later accepted the position of Department Head.

She became Professor of Biomaterials in Regenerative Medicine at the University Hospital Tübingen UKT in 2011, where she coordinates the bachelor 'Vital Implants' and 'Implantology' modules in the Biomedical Technologies program. She was later appointed Interim Institute Director (2016) of the Fraunhofer IGB.